
Ozempic shown to be effective for sustained weight loss
New clinical data has indicated that Ozempic (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by pharmaceutical company Novo Nordisk, is effective for sustained weight loss.